Keryx Treatment Gets Faster FDA Review
Keryx Biopharmaceuticals cancer drug candidate gets faster regulatory review by FDA
09:45AM 12/02/09
China BAK Battery: Pump Up The Volume
Dynegy finished Thursday's session with gains on heavy volume on reports of a possible acquisition by NRG Energy.
03:43PM 09/24/09
Keryx Treatment Gets Special FDA Status
Keryx Biopharmaceuticals cancer drug candidate gets special designation by FDA; shares soar
12:51PM 09/16/09
Biotech and China Still Have Aggressive Trading (RealMoney.com $)
It's narrowed, but there's still an appetite for highly speculative stuff.
02:25PM 06/08/09
Movers Roundup: Headwaters, Keryx Biopharma
Movers roundup: Headwaters drops, Keryx Biopharma gains on kidney treatment trial results
02:21PM 06/08/09
Keryx Shares Jump On Positive Zerenex Study
Keryx Biopharmaceuticals shares jump as kidney disease drug meets midstage study goal
11:04AM 06/08/09
Biotech Stock Mailbag: HEB's Artful Dodging
Readers chime in on Hemispherx, Genxyme, ASCO, Cell Therapeutics and Cardiome.
07:59AM 06/05/09
Tech Leads Big Move Up for Stocks
The Nasdaq rises 54 points as the major averages shake off any blues from GM's bankruptcy filing.
04:43PM 06/01/09
Here's what some of our market pros are saying and playing.
02:39PM 06/01/09
These bruised and battered biotech companies are trying to turn into comeback kids.
08:27PM 05/31/09
Here's what some of our market pros are saying and playing.
03:20PM 05/28/09
Biotech Stock Mailbag: Geron Fans Gone Wild
Readers write in about Amgen, phase III trial upsets, Xoma and Elan, and Geron investors go wild.
07:59AM 03/13/09
Elan's Martin Named Worst Biotech CEO of '08
Kelly Martin is taking home the Nance Trophy for oustanding achievement in loss of shareholder value, overstated optimism and abject incompetence under pressure.
10:44AM 12/11/08



Connect with TheStreet